Published: 2021-09-15 10:04 | Updated: 2021-09-15 10:04

Current calls, week 37, 2021

Tips from KI Grants Office about current calls.

Swedish and Nordic calls

Research grants – Neuroförbundet

Neuroförbundet invites applications for research grants. These support research and development work in medicine and behavioral science related to neurological diseases or injuries, preferably multiple sclerosis. Priority is given to research in the clinical field and research and development work with clinical or practical application with regard to disability needs. Younger researchers are eligible to apply.

Closing date: 30 September 2021

Further information

Haematological research grant – Incyte Biosciences Nordic

This supports research in the field of haematological malignancies and aims to encourage young clinicians to participate in scientific advancement. The grant is worth up to USD 40,000 for two years.

Closing date: 1 October 2021

Further information

Postdoc in radiation protection preparedness – Swedish Radiation Safety Authority

These support two postdocs in radiation protection preparedness. Grants are worth up to SEK 2.7 million.

Closing date: 14 October 2021

Further information

Travel grants to the Lindau Nobel Laureate meeting on chemistry – Royal Swedish Academy of Sciences

Once a year, Nobel Laureates convene in Lindau to meet the next generation of leading scientists; 500–600 undergraduates, PhD students, and post-doc researchers from all over the world. This offers young scientist a unique opportunity to meet scientists from different generations, cultures, and disciplines. Next year’s meeting is dedicated to chemistry. The call for applications from Swedish undergraduates, PhD students, and post-doc researchers to attend the 71st Lindau Nobel Laureate Meeting is now open. These enable young scholars in the fields of chemical sciences and related disciplines to attend the meeting, to be held between 26 June and 1 July 2022 in Lindau, Germany. Grants cover participation costs.

Closing date: 22 October 2021

Further information

Grants for continuing and further research – Swedish Pharmaceutical Society

These support courses, education, conferences, further education and undergraduate education. The total budget is SEK 3.4 million.

Closing date: 31 October 2021

Further information

Postdoctoral grant – Swedish Society for Medical Research (SSMF)

On October15, the call opens for the Swedish Society for Medical Research's three-year grant for postdoctoral education in medical science. The aim is to provide younger researchers with the opportunity to achieve qualifications leading to the establishment of independent research. Applications may be submitted for a grant for full-time or half-time studies. Half-time grants are intended for applicants whose ordinary posts involve clinical practice.

The grant is intended to cover the applicant's salary, including social insurance contributions. The grant administrator for a SSMF post-doctoral grant must be a Swedish university or university college and the recipient of the grant must be employed by the grant administrator throughout the grant period.

Closing date: 15 November 2021

Further information

Collaborative projects – Lundbeck Foundation

This supports integrated, interdisciplinary and collaborative research projects within basic or clinical neuroscience. Applicants should be internationally recognised researchers with a track record of significant research achievements. The collaboration may be between Danish research groups or Danish and international research groups. The main applicant must be affiliated to a Danish host institution. Grants are worth up to DKK 40 million for five years.

Closing date: 6 January 2022

Further information

European calls

ERC-2022-SyG synergy grants -- Horizon Europe: Excellent Science, EU and other funders

These enable groups of 2-4 principal investigators and their teams to bring together complementary skills, knowledge, and resources in new ways to jointly address ambitious research problems. The aim is to promote scientific advances, to cross-fertilise scientific fields, and to encourage new productive lines of enquiry and new methods and techniques, including unconventional approaches and investigations at the interface between established disciplines. Proposals will be evaluated on the sole criterion of scientific excellence, including outstanding intrinsic synergetic effect.

Applicants may be researchers of any age or nationality. Each principal investigator must present an internationally competitive early achievement track-record or a 10-year track record. One of the principal investigators, as well as team members of any principal investigator, may be hosted and engaged by an institution outside the EU member states or associated countries.

Approximately 33 grants are available, each worth up to €10m over six years. An additional €4m can be requested under certain circumstance.

If you are interested in applying for an ERC Synergy Grant, please contact Tamsin Lindström at Grants Office.

Closing date: 10 November 2021

Further information 

Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2021

The MSCA Postdoctoral fellowships aim at fellows who have a PhD degree with maximum eight years of research experience. The postdoc fellow applies together with an identified Principal Investigator for a 2-year European fellowship or a 3-year Global Fellowship which has a mandatory return phase to Europe. The call is open with deadline 12th October 2021.

Closing date: 12 October 2021

Further information

KI information can be found here

For questions contact Ying Zhao 

Marie Skłodowska-Curie Actions (MSCA) Doctoral Networks 2021 (former ITN)

The MSCA Doctoral Networks aim at Consortiums willing to train PhD students, and includes Training Networks (DN), Industrial Doctorates (DN-ID) and Joint Doctorates (DN-JD). The call is open with deadline on 16th November 2021. A Consortium applies for a training program for maximum 10 PhD students for the regular training network, or 15 PhD students for the Joint Doctorate or Industrial Doctorate programs.

Closing date: 16 November 2021

Further information

KI information and instructions

Information and internal requirements for applying for the Joint Doctorates program

For questions contact Ying Zhao 

COMING SOON: International grants  Biocodex Microbiota Foundation, FR

*** This opportunity will be available soon. The next call was expected to open in early July 2021. The following information is subject to change. ***

The Biocodex Microbiota Foundation invites applications for its international grants. These support clinical or fundamental research projects focused on human gut microbiota related to health and disease. For the current round, projects will have to focus on the clinical effects of different microbiota interventions, such as antibiotics, FMT, diet and probiotics, in patients with autism.

Physicians, PhDs and doctors of pharmacy working in subject areas, such as gastroenterology, paediatrics, microbiology, infectious diseases and internal medicine and based anywhere in the world, may apply. Researchers must be affiliated with universities, hospitals or other research settings.

The grant is worth €200,000 over one to three years.

Closing date 30 November 2021 (Forecast)

Further information 

US calls

Federal Funding agencies

BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed), NIH

This FOA solicits applications for research projects that seek to understand how circuit activity gives rise to mental experience and behavior using innovative, methodologically-integrated approaches. The goal is to support adventurous projects that can realize a potentially transformative outcome within 5 years. Applications are expected to address circuit function in the context of specific behaviors or neural systems, such as sensation, perception, attention, reasoning, intention, decision-making, emotion, navigation, communication, or homeostasis. Projects should link theory, data analysis, and/or computational approaches to experimental design and should produce predictive models (conceptual or quantitative). Projects should aim to improve the understanding of circuits of the central nervous system by systematically controlling stimuli and/or behavior while actively recording and/or manipulating dynamic patterns of neural activity. Diverse species or experimental systems and a cross-species/comparative approach are welcome and should be chosen based on their power to address the specific question at hand and to reveal generalizable and fundamental neuroscience principles.

Closing date: November 10, 2021. Letter of Intent Due Date: 30 days prior to the application due date. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-NS-21-013

Further information 

Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01, R21 Clinical Trial Optional), NIH

This Funding Opportunity Announcement (FOA) solicits applications for research projects that will use computational approaches to test the validity of dimensional constructs in the NIMH Research Domain Criteria (RDoC) matrix (or similar constructs based on comparable criteria). Some elements of the RDoC matrix have been updated since its first release, but a thorough data-driven validation that broadly explores, compares, and validates the constructs within the matrix has not been performed. This FOA seeks research that addresses the following questions: Do the different domains of behavior segregate from each other? How much do they rely on distinct versus overlapping neural circuits? What are the relationships between domains, constructs, and subordinate sub-constructs, both in terms of their correlational structure and their underlying neural circuitry? By answering these questions, proposed research projects will test integrative models of functioning and identify dysregulation in psychopathology-related mechanisms that may cut across traditional diagnostic categories and may change over time. This FOA seeks to promote projects where the computational and the experimental components are well integrated. To ensure ecological validity of these studies, models derived from lab-based behavioral tasks will need to be tested for generalizability to behavioral data collected in a real-world setting. The ultimate goal is to advance translational research that will identify novel classification approaches and/or treatment targets, and lead to more effective and timely interventions for serious mental illnesses.

Closing date: November 01, 2021; November 01, 2022; November 01, 2023. Letter of Intent Due Date: 30 days prior to the application due date. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-21-263 (R01), PAR-21-264 (R21)

Further information (R01)

Further information (R21) 

Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01, R21 Clinical Trial Optional), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to support studies to better comprehend the mechanisms contributing to the CNS co-morbidities in people living with HIV on Anti-Retroviral therapy by deciphering the Immune-Central Nervous System (CNS) interactions. Applications testing a fully conceptualized and hypothesis-based premise founded on adequate preliminary data are appropriate for this FOA. Applicants pursuing exploratory and high-risk research projects should be submitted to the companion R21 announcement, RFA-MH-21-251. Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary

Closing date: December 07, 2021. Letter of Intent Due Date: 30 days prior to the application due date. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-MH-21-250 (R01), RFA-MH-21-251 (R21)

Further information (R01)

Further information (R21)


Pilot and feasibility awards - Cystic Fibrosis Foundation, US

The Cystic Fibrosis Foundation invites applications for its pilot and feasibility awards. These support projects that will develop and test new hypotheses or new methods, and promising new investigators as they establish themselves in research areas relevant to cystic fibrosis. The aim is to enable investigators to collect sufficient data to compete successfully for support from the NIH or other funding agencies. Priority will be placed on those projects that propose to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat CF.

Support may be requested for $50,000 per year (plus 12 percent for indirect costs) for up to two years.

Closing date: December 7, 2021.Applications must be submitted by 5 p.m. ET.

Further information 

CFF/NIH-unfunded award, Cystic Fibrosis Foundation, US

The Cystic Fibrosis Foundation invites applications for its CFF/NIH-unfunded award. This supports cystic fibrosis-related research projects that have been submitted to and approved by the National Institutes of Health, but cannot be supported by available NIH funds.

Applications must have been submitted to NIH as an R01/R21 and fall within the upper 40th percentile or to governmental funding agencies in other countries with an NIH R01/R21-equivalent funding programme that provides reviewer critiques and a report indicating the application scored in the upper 40th percentile.

Awards are worth up to USD 125,000 per year for up to two years. Indirect costs are not allowed.

Closing date: Applications must be submitted by 5 p.m. ET on December 31, 2021.

Further information